PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions Read more
Pharmaceutical Microbiology West Coast Conference & Exhibition takes place in less than a week Read more
Aptar Pharma and Propeller Health Partner to Develop Digital Medicine Platform Across Therapeutic Areas Read more
Daiichi Sankyo Announces Launch of Immune-mediated Inflammatory Diseases Consortium for Drug Development Read more
Pfizer Announces FDA Approves XELJANZ (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis Read more
Five Prime Therapeutics Announces Collaboration with Roche to Develop Companion Diagnostics for Targeted Immuno-Oncology Investigational Drug Candidates Read more